EAGLE-1 trial data shows gepotidacin’s potential in treating gonorrhoea, for which no new antibiotics have been approved ...

GSK is opening the door to a new era in urinary tract infection (UTI ... coli, Klebsiella pneumoniae, Citrobacter freundii complex, Staphylococcus saprophyticus or Enterococcus faecalis in ...

Citrobacter freundii complex, Staphylococcus saprophyticus and Enterococcus faecalis. Blujepa is the first in a new class of oral antibiotics for uncomplicated urinary tract infections approved in ...

The U.S. Food and Drug Administration (FDA) has approved Blujepa (gepotidacin), a novel oral antibiotic, for the treatment of uncomplicated urinary tract infections (uUTIs) in adult women and ...

The U.S. Food and Drug Administration just approved the first new antibiotic to treat urinary tract infections in nearly three decades ... coli, Klebsiella pneumoniae, Citrobacter freundii complex, ...

The company said Blujepa represents a significant advancement in UTI treatment ... Klebsiella pneumoniae, Citrobacter freundii complex, Staphylococcus saprophyticus, and Enterococcus faecalis.

TUESDAY, March 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract infections (uUTIs) in adult ...

Among the many latest approvals, the US Food and Drug Administration (FDA) has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract infections (uUTIs) in adult women who ...

A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for ... Klebsiella pneumoniae, Citrobacter freundii complex, Staphylococcus ...

The U.S. Food and Drug Administration just approved the first new antibiotic to treat urinary tract infections in ... Klebsiella pneumoniae, Citrobacter freundii complex, Enterococcus faecalis ...